An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens
Authors:
Preprint
Abstract
Due to failure of virus isolation of Omicron variant in Vero CCL-81 from the clinical specimen’s of COVID-19 cases, we infected Syrian hamsters and then passage into Vero CCL-81 cells. The Omicron sequences were studied to assess if hamster could incorporate any mutation to changes its susceptibility. L212C mutation, Tyrosine 69 deletion, and C25000T nucleotide change in spike gene and absence of V17I mutation in E gene was observed in sequences of hamster passage unlike human clinical specimen and Vero CCL-81 passages. No change was observed in the furin cleavage site in any of the specimen sequence which suggests usefulness of these isolates in future studies.Keywords
This publication has 6 references indexed in Scilit:
- Elucidating the role of N440K mutation in SARS-CoV-2 spike – ACE-2 binding affinity and COVID-19 severity by virtual screening, molecular docking and dynamics approachJournal of Biomolecular Structure and Dynamics, 2021
- N440K variant of SARS-CoV-2 has Higher Infectious FitnessbioRxiv, 2021
- Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profileEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- First isolation of SARS-CoV-2 from clinical samples in IndiaIndian Journal of Medical Research, 2020
- Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in IndiaIndian Journal of Medical Research, 2020
- Complete genome sequencing of Kaisodi virus isolated from ticks in India belonging to Phlebovirus genus, family PhenuiviridaeTicks and Tick-borne Diseases, 2019